Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT07549542
PHASE4

Efficacy and Safety of Intraosseous Antibiotic Prophylaxis in Total Hip Replacement

Sponsor: Rutgers, The State University of New Jersey

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to learn if intraosseous antibiotic (cefazolin) administration can improve antibiotic levels in adults undergoing primary total hip replacement. The main question it aims to answer is: • Does intraosseous cefazolin increase antibiotic concentrations in blood and tissue compared with standard intravenous cefazolin alone? Researchers will compare patients receiving intraosseous cefazolin plus standard intravenous cefazolin to those receiving placebo injection plus standard intravenous cefazolin to see if local antibiotic delivery improves outcomes. Participants will: * Receive standard intravenous cefazolin before surgery and either intraosseous cefazolin or placebo * Provide blood samples before and after antibiotic administration * Have small tissue samples collected during surgery * Complete routine postoperative follow-up and outcome assessment for 90 days

Official title: Efficacy and Safety of Intraosseous Antibiotic Prophylaxis in Total Hip Replacement: A Prospective Randomized Controlled Trial

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

25

Start Date

2025-10-20

Completion Date

2026-11

Last Updated

2026-04-29

Healthy Volunteers

No

Interventions

DRUG

CeFAZolin 1000 MG

1 gram of ancef will be administered intra-osseously into the patient's operative side greater trochanter

DRUG

Saline (0.9%, sterile, for infusion)

normal saline

Locations (1)

Robert Wood Johnson University Hospital Somerset

Somerset, New Jersey, United States